![](/img/cover-not-exists.png)
Preliminary results of a randomised phase III trial of an established chemotherapy (CT) regimen with or without lenograstim (rHuG-CSF) in small cell lung cancer (SCLC): Impact on survival
Gatzemeier, U., Thomas, P., Cardenal, F., Snijder, R.J., Samaras, N., Melo, M.J., Aumann, J., Hermann, R., Puganigg, K., Badri, N.Volume:
33
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(97)85808-X
Date:
September, 1997
File:
PDF, 215 KB
english, 1997